Clinical and economic consequences of ventilator-associated pneumonia: a systematic review N Safdar, C Dezfulian, HR Collard, S Saint Critical care medicine 33 (10), 2184-2193, 2005 | 1505 | 2005 |
Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis CD Pfeiffer, JP Fine, N Safdar Clinical Infectious Diseases 42 (10), 1417-1727, 2006 | 1238 | 2006 |
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials DR Andes, N Safdar, JW Baddley, G Playford, AC Reboli, JH Rex, ... Clinical infectious diseases 54 (8), 1110-1122, 2012 | 908 | 2012 |
The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium … N Safdar, DG Maki Annals of internal medicine 136 (11), 834-844, 2002 | 871 | 2002 |
The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention N Safdar, CJ Crnich, DG Maki Respiratory care 50 (6), 725-741, 2005 | 861 | 2005 |
Adverse effects of isolation in hospitalised patients: a systematic review C Abad, A Fearday, N Safdar Journal of hospital infection 76 (2), 97-102, 2010 | 676 | 2010 |
The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method V Chopra, SA Flanders, S Saint, SC Woller, NP O'Grady, N Safdar, ... Annals of internal medicine 163 (6_Supplement), S1-S40, 2015 | 619 | 2015 |
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis N Safdar, J Handelsman, DG Maki The Lancet infectious diseases 4 (8), 519-527, 2004 | 575 | 2004 |
Crisis communication and public perception of COVID-19 risk in the era of social media KMC Malecki, JA Keating, N Safdar Clinical infectious diseases 72 (4), 697-702, 2021 | 573 | 2021 |
Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis JS Musuuza, L Watson, V Parmasad, N Putman-Buehler, L Christensen, ... PloS one 16 (5), e0251170, 2021 | 528 | 2021 |
The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters N Safdar, DG Maki Intensive care medicine 30, 62-67, 2004 | 526 | 2004 |
The risk of infection after nasal colonization with Staphylococcus aureus N Safdar, EA Bradley The American journal of medicine 121 (4), 310-315, 2008 | 518 | 2008 |
Voriconazole therapeutic drug monitoring J Smith, N Safdar, V Knasinski, W Simmons, SM Bhavnani, PG Ambrose, ... Antimicrobial agents and chemotherapy 50 (4), 1570-1572, 2006 | 499 | 2006 |
Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients N Safdar, DG Maki Chest 128 (2), 489-495, 2005 | 478 | 2005 |
Meta-analysis: methods for diagnosing intravascular device–related bloodstream infection N Safdar, JP Fine, DG Maki Annals of Internal Medicine 142 (6), 451-466, 2005 | 461 | 2005 |
Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina VD Rosenthal, S Guzman, N Safdar American journal of infection control 33 (7), 392-397, 2005 | 457 | 2005 |
The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis V Chopra, JC O'Horo, MAM Rogers, DG Maki, N Safdar Infection Control & Hospital Epidemiology 34 (9), 908-918, 2013 | 412 | 2013 |
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic … A Kumar, N Safdar, S Kethireddy, D Chateau Critical care medicine 38 (8), 1651-1664, 2010 | 411 | 2010 |
In vivo pharmacodynamic activity of daptomycin N Safdar, D Andes, WA Craig Antimicrobial agents and chemotherapy 48 (1), 63-68, 2004 | 405 | 2004 |
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study N Singh, AP Limaye, G Forrest, N Safdar, P Munoz, K Pursell, S Houston, ... Transplantation 81 (3), 320-326, 2006 | 396 | 2006 |